U.S. Markets close in 1 hr, 51 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,309.92 | -154.48 | -1.48% |
| NASDAQ | 2,138.44 | -37.61 | -1.73% |
| S&P 500 | 1,091.49 | -19.14 | -1.72% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 52.43 09:38 AM EST | |
|---|---|---|
| Day High | 53.73 11:03 AM EST |
|
| Range | 1.30 |
| Volume | 120,857 | |
|---|---|---|
| 30-Day Avg Vol | 742,000 |
|
| Difference | -83.71% |
| Market Cap | 3.41 B | |
|---|---|---|
| Mkt Cap Chg | -37.13 M |
| Shares Out | 64.02 M | |
|---|---|---|
| % Shrs Traded | 0.19% | |
| 1yr EPS Est | 2.878 |
| 52-Wk Low | 32.31 | |
|---|---|---|
| 52-Wk High | 58.95 |
|
| Range | 26.64 |
| Prev Close | 53.88 11/25/09 | |
|---|---|---|
| Today's Open | 52.46 | |
| Change | -2.64% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 6.3 M |
| Revenue (LFY) | 1.82 B | |
|---|---|---|
| Earnings (LFY) | 196.76 M | |
| Earnings (MRQ) | 51.06 M | |
| Next Earn Est | 0.655 | |
| Next Earnings | 01/25/2010 |
|
| EPS (TTM) | 2.81 | |
| 1yr EPS Growth | 7.39% |
| P/E Ratio (TTM) | 18.97 | |
|---|---|---|
| P/E Ratio (Fwd) | 18.00 | |
| PEG Ratio | 1.30 | |
| Return on Equity | 17.20 | |
| Beta | 1.04 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Health Services |
above for more info
Behind every great drug company stands a great contract research organization (CRO), and Covance is one of the biggest. Covance helps pharmaceutical and biotech companies develop new drugs, providing preclinical ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.655 1/25/10 | — — |
—
—
|
| Last Quarter | 0.666 9/30/09 | 0.67 9/30/09 |
0.004
Beat
|
| 2 Quarters Ago | 0.634 6/30/09 | 0.66 6/30/09 |
0.026
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 493.72 M | 1.83 B |
| Gross Profit | 127.32 M | 513.83 M |
| Operating Income | 57.80 M | 263.65 M |
| Net Income | 51.06 M | 196.76 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts